Similarly, macrophage-targeted single-walled carbon nanotubes loaded with CD47-SIRPα signaling inhibitors can enhance efferocytosis in lesion macrophages and reduce atherosclerosis (Flores et al., 2020). Here, CD47 is linked to atherosclerosis.